Relationship among endothelial response to hyperemia, bone marrow-derived progenitor cells, and parathyroid hormone in renal transplantation

Transplantation

Volumn 93, Issue 8, 2012, Pages 835-841

  Fatini, Cinzia ^a   Sticchi, Elena ^a,b   Cesari, Francesca ^a   Gori, Anna Maria ^a   Cioni, Gabriele ^a   De Stefano, Margherita ^a   Bertoni, Elisabetta ^a   Paudice, Nunzia ^a   Salvadori, Maurizio ^a   Zanazzi, Maria ^a   Abbate, Rosanna ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

CPCs; EPCs; Parathyroid hormone; Peripheral arterial tonometry (PAT); Renal transplantation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CD133 ANTIGEN; CD34 ANTIGEN; CORTICOSTEROID; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EVEROLIMUS; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOPHENOLIC ACID; PARATHYROID HORMONE; RAPAMYCIN; TACROLIMUS; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL COUNT; CIRCULATING STEM CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; ENOS GENE; FEMALE; FLOW CYTOMETRY; GENE; GENETIC POLYMORPHISM; HEMATOPOIETIC STEM CELL; HEMODIALYSIS; HUMAN; HYPEREMIA; HYPERTENSION; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TONOMETRY; TREATMENT DURATION;

ADULT; AGED; BONE MARROW CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPEREMIA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; PARATHYROID HORMONE; POLYMORPHISM, GENETIC; STEM CELLS; YOUNG ADULT;

EID: 84859630273     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318247a75d     Document Type: Article

References (31)

1. Foley RN, Parfrey PS, Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: 112.
2. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction. A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168.
3. Hingorani AD. Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis 2000; 154: 521.
4. Cesari F, Nencini P, Nesi M, et al. Bone marrow-derived progenitor cells in the early phase of ischemic stroke: Relation with stroke severity and discharge outcome. J Cereb Blood Flow Metab 2009; 29: 1983.
5. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701.
6. Steiner S, Winkelmayer WC, Kleinert J, et al. Endothelial progenitor cells in kidney transplant recipients. Transplantation 2006; 81: 599.
7. Soler MJ, Martínez-Estrada OM, Puig-Marí JM, et al. Circulating endothelial progenitor cells after kidney transplantation. Am J Transplant 2005; 5: 2154.
8. Ozüyaman B, Ebner P, Niesler U, et al. Nitric oxide differentially regulates proliferation and mobilization of endothelial progenitor cells but not of hematopoietic stem cells. Thromb Haemost 2005; 94: 770.
9. Van Craenenbroeck EM, Conraads VM. Endothelial progenitor cells in vascular health: Focus on lifestyle. Microvasc Res 2010; 79: 184.
10. Fadini GP, Pagano C, Baesso I, et al. Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma. Acta Ophthalmol 2010; 88: 135.
11. Kuvin JT, Patel AR, Sliney KA, et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 2003; 146: 168.
12. Hamburg NM, Keyes MJ, Larson MG, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008; 117: 2467.
13. Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 2010; 31: 1142.
14. Coen G, Manni M, Mantella D, et al. ArePTHserum levels predictive of coronary calcifications in haemodialysis patients? Nephrol Dial Transplant 2007; 22: 3262.
15. Baykan M, Erem C, Erdooan T, et al. Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism. Int J Cardiovasc Imaging 2007; 23: 323.
16. Kosch M, Hausberg M, Vormbrock K, et al. Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc Res 2000; 47: 813.
17. Fernández-Fresnedo G, Rodrigo E, Ruiz JC, et al. Bone metabolism according to chronic kidney disease stages in patients undergoing kidney transplantation: A 5-year database analysis. Transplant Proc 2009; 41: 2403.
18. Ganesh SK, Stack AG, Levin NW, et al. Association of elevated serum PO(4), Cax PO(4) product, and parathyroidhormonewith cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131.
19. Michaud SE, Dussault S, Haddad P, et al. Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 2006; 187: 423.
20. Gallagher KA, Liu ZJ, Xiao M, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007; 117: 1249.
21. Hill JM, Finkel T, Quyyumi AA. Endothelial progenitor cells and endothelial dysfunction. Vox Sang 2004; 87: 31.
22. Wang R,WuLY, Karpinski E, et al. The effects of parathyroid hormone on L-type voltage-dependent calcium channel currents in vascular smooth muscle cells and ventricular myocytes are mediated by a cyclic AMP dependent mechanism. FEBS Lett 1991; 282: 331.
23. Vaziri ND, Ni Z, Wang XQ, et al. Downregulation of nitric oxide synthase in chronic renal insufficiency: Role of excess PTH. Am J Physiol 1998; 274: F642.
24. Lomonte C, Derosa C, Vernaglione L, et al. Serum parathyroid hormone and phosphate influence the levels of circulating CD34+ cells in uremia. J Nephrol 2010; 23: 693.
25. Schlieper G, Hristov M, Brandenburg V, et al. Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients. Nephrol Dial Transplant 2008; 23: 2611.
26. Kasiske BL, Vazquez MA, Harmon WE, et al. Recommendations for the outpatient surveillance of renal transplant recipients American Society of Transplantation. J Am Soc Nephrol 2000; 11: S1.
27. Practice guidelines for primary care physicians: 2003 ESH/ESC Hypertension guidelines. ESH/ESC hypertension guidelines committee. Hypertension 2003; 21: 1779.
28. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26: S5.
29. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adult (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143.
30. Sofi F, Marcucci R, Fedi S, et al. High lipoprotein (a) levels are associated with an increased risk of retinal vein occlusion. Atherosclerosis 2010; 210: 278.
31. Fatini C, Sofi F, Sticchi E, et al. Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J 2004; 147: 516.